Company biote Corp.

Equities

BTMD

US0906831039

Professional Information Services

Market Closed - Nasdaq 21:00:00 10/05/2024 BST 5-day change 1st Jan Change
6.12 USD -2.08% Intraday chart for biote Corp. +1.83% +23.89%

Business Summary

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Number of employees: 194

Managers

Managers TitleAgeSince
Chief Executive Officer 71 30/04/22
Director of Finance/CFO 47 01-07
Chief Tech/Sci/R&D Officer 62 31/05/19
Chief Tech/Sci/R&D Officer 52 09/06/22
Corporate Officer/Principal - 29/05/23
Human Resources Officer 51 -
General Counsel 44 31/05/21
Sales & Marketing 54 -
Corporate Officer/Principal 61 30/04/22

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 30/04/22
Director/Board Member 66 30/04/22
Chairman 59 30/04/22
Director/Board Member 65 02/11/22
Chief Executive Officer 71 30/04/22
Director/Board Member 49 30/04/22
Director/Board Member 61 30/04/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,819,066 0 10,000,000 ( 20.48 %) 71.98 %
Stock B 1 37,802,310 27,210,228 ( 71.98 %) 1,587,500 ( 4.199 %)

Shareholders

NameEquities%Valuation
325 Capital LLC
10.55 %
3,766,666 10.55 % 22 M $
Roystone Capital Management LP
8.599 %
3,070,938 8.599 % 18 M $
Haymaker Sponsor III LLC
5.232 %
1,868,556 5.232 % 11 M $
Bandera Partners LLC
5.132 %
1,832,732 5.132 % 11 M $
Vanguard Fiduciary Trust Co.
3.975 %
1,419,529 3.975 % 8 M $
FPR Partners LLC
3.082 %
1,100,766 3.082 % 6 M $
BlackRock Advisors LLC
2.640 %
942,958 2.640 % 5 M $
Kanen Wealth Management LLC
2.346 %
837,643 2.346 % 5 M $
Boston Partners Global Investors, Inc.
2.324 %
829,927 2.324 % 5 M $
SW Investment Management LLC
1.890 %
675,000 1.890 % 4 M $

Company contact information

biote Corp.

1875 West Walnut Hill Lane Suite 100

75038, Irving

+

http://www.biote.com
address biote Corp.(BTMD)